Oltenfreiter R - Search Results

1

Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital.

Lambert B, Sturm E, Mertens J, Oltenfreiter R, Smeets P, Troisi R, Van Vlierberghe H, Defreyne L. Lambert B, et al. Among authors: oltenfreiter r. Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2117-24. doi: 10.1007/s00259-011-1881-2. Epub 2011 Jul 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 21792571

2

Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging.

Van De Wiele C, Oltenfreiter R, De Winter O, Signore A, Slegers G, Dierckx RA. Van De Wiele C, et al. Among authors: oltenfreiter r. Eur J Nucl Med Mol Imaging. 2002 May;29(5):699-709. doi: 10.1007/s00259-002-0783-8. Epub 2002 Mar 22. Eur J Nucl Med Mol Imaging. 2002. PMID: 11976811 Review.

3

In vivo imaging of apoptosis in oncology: an update.

Vangestel C, Peeters M, Mees G, Oltenfreiter R, Boersma HH, Elsinga PH, Reutelingsperger C, Van Damme N, De Spiegeleer B, Van de Wiele C. Vangestel C, et al. Among authors: oltenfreiter r. Mol Imaging. 2011 Oct;10(5):340-58. doi: 10.2310/7290.2010.00058. Epub 2011 Apr 26. Mol Imaging. 2011. PMID: 21521554 Review.

4

Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography.

Courtyn J, Cornelissen B, Oltenfreiter R, Vandecapelle M, Slegers G, Strijckmans K. Courtyn J, et al. Among authors: oltenfreiter r. Nucl Med Biol. 2004 Jul;31(5):649-54. doi: 10.1016/j.nucmedbio.2003.11.001. Nucl Med Biol. 2004. PMID: 15219284

5

In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.

Vangestel C, Peeters M, Oltenfreiter R, D'Asseler Y, Staelens S, Van Steenkiste M, Philippé J, Kusters D, Reutelingsperger C, Van Damme N, Van de Wiele C. Vangestel C, et al. Among authors: oltenfreiter r. Nucl Med Biol. 2010 Nov;37(8):965-75. doi: 10.1016/j.nucmedbio.2010.06.007. Epub 2010 Sep 20. Nucl Med Biol. 2010. PMID: 21055628

6

New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.

Oltenfreiter R, Staelens L, Lejeune A, Dumont F, Frankenne F, Foidart JM, Slegers G. Oltenfreiter R, et al. Nucl Med Biol. 2004 May;31(4):459-68. doi: 10.1016/j.nucmedbio.2003.10.013. Nucl Med Biol. 2004. PMID: 15093816 Free article.

7

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker.

Cornelissen B, Oltenfreiter R, Kersemans V, Staelens L, Frankenne F, Foidart JM, Slegers G. Cornelissen B, et al. Among authors: oltenfreiter r. Nucl Med Biol. 2005 Jul;32(5):431-6. doi: 10.1016/j.nucmedbio.2005.03.005. Nucl Med Biol. 2005. PMID: 15982572 Free article.

8

In vivo evaluation of [(123)I]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one: a presumed dopamine D4 receptor ligand for SPECT studies.

Staelens L, Oltenfreiter R, Blanckaert P, Kersemans V, Vandenbulcke K, Van De Wiele C, Slegers G. Staelens L, et al. Among authors: oltenfreiter r. Nucl Med Biol. 2005 Apr;32(3):293-9. doi: 10.1016/j.nucmedbio.2004.12.006. Nucl Med Biol. 2005. PMID: 15820765

9

In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies.

Staelens L, Oltenfreiter R, Dumont F, Waterhouse RN, Vandenbulcke K, Blanckaert P, Dierckx RA, Slegers G. Staelens L, et al. Among authors: oltenfreiter r. Nucl Med Biol. 2005 Feb;32(2):193-200. doi: 10.1016/j.nucmedbio.2004.09.007. Nucl Med Biol. 2005. PMID: 15721765

10

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.

Cornelissen B, Kersemans V, Burvenich I, Oltenfreiter R, Vanderheyden JL, Boerman O, Vandewiele C, Slegers G. Cornelissen B, et al. Among authors: oltenfreiter r. Nucl Med Commun. 2005 Feb;26(2):147-53. doi: 10.1097/00006231-200502000-00012. Nucl Med Commun. 2005. PMID: 15657509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters